Lack of EVER2 protein in two epidermodysplasia verruciformis patients with skin cancer presenting previously unreported homozygous genetic deletions in the EVER2 gene

Journal of Investigative Dermatology

Volumn 132, Issue 4, 2012, Pages 1305-1308

  Landini, Manuela M ^a   Zavattaro, Elisa ^a   Borgogna, Cinzia ^a,b   Azzimonti, Barbara ^a   De Andrea, Marco ^a,c   Colombo, Enrico ^a   Marenco, Federica ^d   Amantea, Ada ^e   Landolfo, Santo ^c   Gariglio, Marisa ^a  

^a Amedeo Avogadro University   (Italy)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; PROTEIN; PROTEIN EVER1; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; BOWEN DISEASE; CASE REPORT; CONTROLLED STUDY; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE DELETION; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 14; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN TISSUE; LETTER; MALE; MUTATIONAL ANALYSIS; OPEN READING FRAME; PEDIGREE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; STOP CODON; VIRUS CARRIER; VIRUS LOAD; WART VIRUS;

EID: 84858276694     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.399     Document Type: Letter

References (17)

1. Akgul B, Cooke JC, Storey A (2006) HPVassociated skin disease. J Pathol 208:165-75
2. Azzimonti B, Mondini M, De Andrea M et al. (2005) CD8+ T-cell lymphocytopenia and lack of EVER mutations in a patient with clinically and virologically typical epidermodysplasia verruciformis. Arch Dermatol 141:1323-5
3. Bernard HU, Burk RD, Chen Z et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-9
4. Berthelot C, Dickerson MC, Rady P et al. (2007) Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod. J Am Acad Dermatol 56:882-5
5. Bhuvanagiri M, Schlitter AM, Hentze MW et al. (2010) NMD: RNA biology meets human genetic medicine. Biochem J 430:365-77
6. Bouwes Bavinck JN, Neale RE, Abeni D et al. (2011) Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 70:9777-85
7. Bravo IG, de Sanjose S, Gottschling M (2010) The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol 18:432-8
8. Dell'Oste V, Azzimonti B, De Andrea M et al. (2009) High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 129:1026-34
9. Jablonska S, Majewski S (1994) Epidermodysplasia verruciformis: Immunological and clinical aspects. Curr Top Microbiol Immunol 186: 157-75
10. Lazarczyk M, Cassonnet P, Pons C et al. (2009) The EVER proteins as a natural barrier against papillomaviruses: A new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 73:348-70
11. Orth G (2006) Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol 18:362-74
12. Proby CM, Harwood CA, Neale RE et al. (2011) A Case-Control Study of Betapapillomavirus Infection and Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. Am J Transplant 11:1498-508
13. Rady PL, De Oliveira WR, He Q et al. (2007) Novel homozygous nonsense TMC8 mutation detected in patients with epidermodysplasia verruciformis from a Brazilian family. Br J Dermatol 157:831-3
14. Ramoz N, Rueda LA, Bouadjar B et al. (2002) Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579-81
15. Sun XK, Chen JF, Xu AE (2005) A homozygous nonsense mutation in the EVER2 gene leads to epidermodysplasia verruciformis. Clin Exp Dermatol 30:573-4
16. Weissenborn SJ, De Koning MN, Wieland U et al. (2009) Intrafamilial transmission and familyspecific spectra of cutaneous betapapillomaviruses. J Virol 83:811-5
17. Zavattaro E, Azzimonti B, Mondini M et al. (2008) Identification of defective Fas function and variation of the perforin gene in an epidermodysplasia verruciformis patient lacking EVER1 and EVER2 mutations. J Invest Dermatol 128:732-5